Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)
DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)
DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink
DJ Innate Pharma在SVB Leerink的市場演出中保持不變
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 19, 2021 06:30 ET (10:30 GMT)
2021年3月19日東部時間06:30(格林尼治標準時間10:30)
DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
DJ先天醫藥目標價被SVB Leerink從每股5.00美元上調至7.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 19, 2021 06:30 ET (10:30 GMT)
2021年3月19日東部時間06:30(格林尼治標準時間10:30)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧